97 related articles for article (PubMed ID: 3792937)
1. cis-Diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer.
Piver MS; Lele SB; Malfetano JH
Gynecol Oncol; 1987 Jan; 26(1):71-6. PubMed ID: 3792937
[TBL] [Abstract][Full Text] [Related]
2. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
Lee YY; Park W; Huh SJ; Yoon A; Park JY; Choi CH; Kim TJ; Lee JW; Kim BG; Bae DS
Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
[TBL] [Abstract][Full Text] [Related]
3. 1.5-5 years of uninterrupted cis-diamminedichloroplatinum II chemotherapy for metastatic cervical cancer.
Piver MS; Lele SB; Patsner B; McPhee ME
Gynecol Oncol; 1987 May; 27(1):24-33. PubMed ID: 3570047
[TBL] [Abstract][Full Text] [Related]
4. Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix: a pilot study.
Malviya VK; Deppe G; Kim Y; Gove N
Am J Clin Oncol; 1989 Oct; 12(5):434-7. PubMed ID: 2508463
[TBL] [Abstract][Full Text] [Related]
5. Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases.
Malfetano JH; Keys H
Gynecol Oncol; 1991 Jul; 42(1):44-7. PubMed ID: 1916509
[TBL] [Abstract][Full Text] [Related]
6. Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.
Park TK; Kwon JY; Kim SW; Kim SH; Kim SN; Kim GE
Int J Clin Oncol; 2004 Apr; 9(2):120-4. PubMed ID: 15108044
[TBL] [Abstract][Full Text] [Related]
7. Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study.
Twiggs LB; Potish RA; McIntyre S; Adcock LL; Savage JE; Prem KA
Gynecol Oncol; 1986 Jun; 24(2):143-8. PubMed ID: 3086189
[TBL] [Abstract][Full Text] [Related]
8. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer.
Angioli R; Plotti F; Montera R; Aloisi A; Luvero D; Capriglione S; Terranova C; De Cicco Nardone C; Muzii L; Benedetti-Panici P
Gynecol Oncol; 2012 Nov; 127(2):290-6. PubMed ID: 22819938
[TBL] [Abstract][Full Text] [Related]
10. Combination cyclophosphamide, adriamycin, and cis-platinum in recurrent and metastatic cervical carcinoma.
De Murua EO; George M; Pejovic MH; Dewailly J; Wolff JP
Gynecol Oncol; 1987 Feb; 26(2):225-7. PubMed ID: 3804038
[TBL] [Abstract][Full Text] [Related]
11. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
12. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
13. Clinical Observation of Prophylactic Extended-Field Intensity-Modulated Radiation Therapy with Synchronous Chemotherapy in Locally Advanced Cervical Cancer.
Huang X; Fang M; Zhu L; Gu C; Cui H; Yang C; Yang Y
Med Sci Monit; 2021 Sep; 27():e930457. PubMed ID: 34489390
[TBL] [Abstract][Full Text] [Related]
14. Effect of cis-platinum on tolerance to radiation therapy in advanced cervical cancer.
Potish RA; Twiggs LB; Adcock LL; Savage JE; Prem KA; Levitt SH
Am J Clin Oncol; 1986 Oct; 9(5):387-91. PubMed ID: 3776900
[TBL] [Abstract][Full Text] [Related]
15. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
[TBL] [Abstract][Full Text] [Related]
16. Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stages Ib and II with bulky tumor.
Kim DS; Moon H; Kim KT; Hwang YY; Cho SH; Kim SR
Gynecol Oncol; 1989 May; 33(2):225-30. PubMed ID: 2467848
[TBL] [Abstract][Full Text] [Related]
17. [A case of paratesticular rhabdomyosarcoma with a paraaortic lymph node metastasis].
Nakanishi H; Nakagawa S; Mikami K; Nomoto T; Urano S; Nakamura T; Watanabe H
Hinyokika Kiyo; 1997 Mar; 43(3):233-6. PubMed ID: 9127762
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic lymph node dissection should be performed before fertility preserving treatment of patients with cervical cancer.
Vercellino GF; Piek JM; Schneider A; Köhler C; Mangler M; Speiser D; Chiantera V
Gynecol Oncol; 2012 Sep; 126(3):325-9. PubMed ID: 22704949
[TBL] [Abstract][Full Text] [Related]
19. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
[TBL] [Abstract][Full Text] [Related]
20. Cis-platinum, doxorubicin, and methotrexate treatment for recurrent cervical cancer.
Wheelock JB; Krebs HB; Goplerud DR; Myers M
Obstet Gynecol; 1985 Sep; 66(3):410-2. PubMed ID: 4040622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
